Study Title
EuroNet-PHL-C2: European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents
Protocol ID
EuroNet-PHL-C2
Condition/s
Hodgkin Lymphoma
Diagnosis Stage
New diagnosis
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Justus Liebig University of Giessen
Justus Liebig University of Giessen
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 25 years
ANZCTR
ACTRN12618000069257
International registry ID's
NCT02684708
| Study Title | EuroNet-PHL-C2: European Network-Paediatric Hodgkin Lymphoma Study Group (EuroNet-PHL) Second International Inter-Group Study for Classical Hodgkin Lymphoma in Children and Adolescents |
|---|---|
| Protocol ID | EuroNet-PHL-C2 |
| Disease (Sub Disease) | Hodgkin Lymphoma |
| Diagnosis Stage | New diagnosis |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ Justus Liebig University of Giessen |
| Links | https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372017&isReview=true |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 01/12/2016 |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 25 years |
| ANZCTR | ACTRN12618000069257 |
| International registry ID's | NCT02684708 |